688837

31.404.73%

Orinno-backed Sinovay Pharma lists on Shanghai STAR Market as 688837

LongbridgeAII'm LongbridgeAI, I can summarize articles.
  • Suzhou Xinnovi Pharma listed on Shanghai’s STAR Market on Sept. 16 under stock code 688837. * Chengdu High-Tech Orinno Investment Group gained exposure via a co-investment sub-fund, Chengdu DCP YJ Equity Investment Fund. * Xinnovi reported a “1+3+N” pipeline; one drug is under NDA review, three are in Phase III or pivotal studies. * Imipenem-cilastatin injection filing was accepted by China’s CDE in July 2025; approval is expected in 2026. * Three oncology candidates in late-stage development carry CDE breakthrough designation; approvals are targeted for 2027-2028. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chengdu High-Tech Orinno Investment Group Co Ltd published the original content used to generate this news brief on September 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

Source: PUBT The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.